a protein made by the immune system during an immune response that attaches to specific cells and can affect the immune system's ability to target and kill cells.
a stage of SCLC (small cell lung cancer) when the cancer has spread outside of the lung in which it began, or to other parts of the body.
a collection of organs, special cells, and substances that help protect you from infections and other diseases.
a treatment using substances that stimulate or suppress the immune system to help the body fight cancer, infection, and disease. Some types of immunotherapy only target certain cells of the immune system. Others affect the immune system in a general way. Immunotherapy may also affect normal cells.
a method of putting fluids, including medicines, into the bloodstream. Also called intravenous (IV) infusion.
any sign or symptom you might experience during or soon after the infusion of fluids, including medicines, into the bloodstream.
the middle value, or number, in a set of measurements that have been put in order from lowest to highest.
the spread of cancer from where it originated to other places in the body.
the length of time from the start of diagnosis or treatment for a disease, such as cancer, that patients in a clinical trial are still alive. Median OS is the length of time that half of these patients are still alive.
what small cell lung cancer (SCLC) is sometimes called.
a protein found on the surface of many cells, including cancer cells, that can affect the immune system’s ability to target and attack cells.
the length of time during and after the treatment of cancer, that a patient in a clinical trial lives with cancer but it does not get worse. Median PFS is the length of time at which half the patients lived without their tumors growing or spreading.
a molecule that is the building block of the cells in the body, needed for the body to function properly.
an aggressive (fast-growing) cancer that forms in tissues of the lung and can spread to other parts of the body.
Find information about TECENTRIQ® (atezolizumab) for extensive-stage small cell lung cancer (ES-SCLC). Watch the end of the video for full important safety information.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.